<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Neurology</journal-id><journal-id journal-id-type="iso-abbrev">Neurology</journal-id><journal-id journal-id-type="pmc-domain-id">798</journal-id><journal-id journal-id-type="pmc-domain">neurology</journal-id><journal-id journal-id-type="publisher-id">neur</journal-id><journal-id journal-id-type="publisher-id">NEUROLOGY</journal-id><journal-title-group><journal-title>Neurology</journal-title></journal-title-group><issn pub-type="ppub">0028-3878</issn><issn pub-type="epub">1526-632X</issn><publisher><publisher-name>American Academy of Neurology</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10491435</article-id><article-id pub-id-type="pmcid-ver">PMC10491435.1</article-id><article-id pub-id-type="pmcaid">10491435</article-id><article-id pub-id-type="pmcaiid">10491435</article-id><article-id pub-id-type="pmid">37407266</article-id><article-id pub-id-type="doi">10.1212/WNL.0000000000207580</article-id><article-id pub-id-type="publisher-id">WNL-2023-000395</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="hwp-journal-coll"><subject>222</subject><subject>54</subject><subject>60</subject><subject>61</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Utilization of Antiseizure Medications in Women of Childbearing Age With Epilepsy and Nonepilepsy Indications</article-title><subtitle>A Retrospective Cohort Study</subtitle></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4466-6675</contrib-id><name name-style="western"><surname>Lawal</surname><given-names initials="OD">Oluwadolapo D.</given-names></name><degrees>PhD, MPH</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meador</surname><given-names initials="KJ">Kimford J.</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hume</surname><given-names initials="AL">Anne L.</given-names></name><degrees>PharmD</degrees></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Wen</surname><given-names initials="X">Xuerong</given-names></name><degrees>PhD, MPH</degrees></contrib><aff>From the Department of Pharmacy Practice (O.D.L., A.L.H., X.W.), College of Pharmacy, University of Rhode Island, Kingstown; and Department of Neurology &amp; Neurological Sciences (K.J.M.), Stanford University School of Medicine, CA.</aff></contrib-group><author-notes><corresp><bold>Correspondence</bold> Dr. Wen <email>xuerongwen@uri.edu</email></corresp><fn fn-type="financial-disclosure"><p>Go to <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://n.neurology.org/lookup/doi/10.1212/WNL.0000000000207580" ext-link-type="uri">Neurology.org/N</ext-link> for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.</p></fn><fn fn-type="other"><p>Submitted and externally peer reviewed. The handling editor was Associate Editor Barbara Jobst, MD, PhD, FAAN.</p></fn></author-notes><pub-date pub-type="ppub"><day>5</day><month>9</month><year>2023</year></pub-date><volume>101</volume><issue>10</issue><issue-id pub-id-type="pmc-issue-id">445007</issue-id><fpage>e1083</fpage><lpage>e1096</lpage><history><date date-type="received"><day>02</day><month>8</month><year>2022</year></date><date date-type="accepted"><day>10</day><month>5</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>05</day><month>09</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>05</day><month>09</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-11 20:25:15.563"><day>11</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 American Academy of Neurology</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>American Academy of Neurology</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="WNL-2023-000395.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="pdf" xlink:href="WNL-2023-000395.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="abridged-pdf" xlink:href="e1083.abridged.pdf"/><abstract><sec><title>Background and Objectives</title><p>Antiseizure medications (ASMs) are among the most commonly prescribed teratogenic drugs in women of childbearing age. Limited data exist on utilization patterns across different indications for therapy and for the newer-generation ASMs in this population. Thus, we assessed the pattern of ASM use in women of childbearing age with epilepsy and nonepilepsy indications (pain and psychiatric disorders).</p></sec><sec><title>Methods</title><p>We conducted a retrospective analysis of deidentified administrative data submitted to the Optum Clinformatics database. Eligible participants included women aged 12&#8211;50 years who filled ASMs between year 2011 and 2017. Participants were followed from date of index prescription filled to study end or insurance disenrollment, whichever came first. For the overall cohort and potential therapy indications, we assessed the type and frequency of ASMs filled; proportion of participants on monotherapy, polytherapy, or treatment switching; and duration of continuous use. Trends were characterized using annual percent change from study start to study end.</p></sec><sec><title>Results</title><p>Our analysis included 465,131 participants who filled 603,916 distinct ASM prescriptions. At baseline, most of the participants had chronic pain (51.0%) and psychiatric disorders (32.7%), with epilepsy the least common (0.9%). The most frequently dispensed were diazepam (24.3%), lorazepam (20.1%), gabapentin (17.4%), clonazepam (12.7%), topiramate (11.3%), and lamotrigine (4.6%). Significant linear increase in trends were observed with gabapentin (annual percent change [95% CI]: 8.4 [7.3&#8211;9.4]; <italic toggle="yes">p</italic> &lt; 0.001) and levetiracetam (3.4 [0.7&#8211;6.2]; <italic toggle="yes">p</italic> = 0.022) and decreasing trends for diazepam (&#8722;3.5 [&#8722;2.4 to 4.5]; <italic toggle="yes">p</italic> &lt; 0.001) and clonazepam (&#8722;3.4 [&#8722;2.3 to 4.5]; <italic toggle="yes">p</italic> = 0.001). No significant change in trend was observed with valproate (&#8722;0.4 [&#8722;2.7 to 1.9]; <italic toggle="yes">p</italic> = 0.651), while nonlinear changes in trends were observed with lorazepam, topiramate, lamotrigine, and pregabalin.</p></sec><sec><title>Discussion</title><p>Decreasing trends were observed with older ASMs in the overall cohort and across the potential indications for therapy. Conversely, increasing trends were seen with the newer ASMs. Considering the risk of teratogenicity associated with the newer medications largely unknown, counseling and education in addition to a careful consideration of the benefits vs potential risks should remain pivotal when prescribing ASMs for women of childbearing age.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>